NeuroOne Medical Technologies Corporation (NMTC) financial statements (2022 and earlier)

Company profile

Business Address 7599 ANAGRAM DR
EDEN PRAIRIE, MN 55344
State of Incorp. DE
Fiscal Year End September 30
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2019
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments16,1846,9014,03626126 2
Cash and cash equivalents16,1846,9014,03626126 2
Receivables2548     
Inventory, net of allowances, customer advances and progress billings22998     
Inventory22998     
Prepaid expense137244119417  
Disposal group, including discontinued operation     4 
Total current assets:16,5767,2924,1553023442
Noncurrent Assets
Operating lease, right-of-use asset263289282 
Property, plant and equipment21722316652   
Intangible assets, net (including goodwill)129134157179216  
Intangible assets, net (excluding goodwill)129134157179216  
Total noncurrent assets:608646605231216  
TOTAL ASSETS:17,1837,9384,76053325042
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,0601,1731,2751,7701,0222217
Accounts payable7045297631,152 2217
Accrued liabilities3566445136181,022  
Debt  1,007 2,421 14
Due to related parties     7453
Disposal group, including discontinued operation     22 
Other undisclosed current liabilities2973 462  
Total current liabilities:1,0621,1822,3561,7703,90511883
Noncurrent Liabilities
Long-term debt and lease obligation173203254    
Operating lease, liability173203254 
Other undisclosed noncurrent liabilities(173)(203)(171) 1,381  
Total noncurrent liabilities:173203338 1,381  
Total liabilities:1,2361,3852,6941,7705,28711883
Stockholders' equity
Stockholders' equity attributable to parent, including:15,9486,5542,066(1,238)(5,037)(114)(81)
Common stock40362213855
Additional paid in capital59,54247,34532,92315,9882804693
Accumulated deficit(43,635)(40,827)(30,879)(17,239)(5,325)(228)(180)
Other undisclosed stockholders' equity attributable to parent     64 
Total stockholders' equity:15,9486,5542,066(1,238)(5,037)(114)(81)
TOTAL LIABILITIES AND EQUITY:17,1837,9384,76053325042

Income statement (P&L) ($ in thousands)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2019
12/31/2017
12/31/2016
12/31/2015
Revenues140178    1
Revenue, net  1
Cost of revenue(214)(276)     
Gross profit:(73)(98)    1
Operating expenses(10,860)(10,185)(6,829)(5,813)(77)(33)(50)
Other undisclosed operating income49651,927    
Operating loss:(10,884)(10,218)(4,902)(5,813)(77)(33)(49)
Nonoperating income
(Other undisclosed Nonoperating income)
85      
Interest and debt expense  (2,018)(553)(35) (14)
Other undisclosed loss from continuing operations before equity method investments, income taxes(270)      
Loss from continuing operations before equity method investments, income taxes:(11,069)(10,218)(6,920)(6,367)(112)(33)(63)
Other undisclosed income from continuing operations before income taxes3      
Loss from continuing operations before income taxes:(11,066)(10,218)(6,920)(6,367)(112)(33)(63)
Income tax benefit 271     
Other undisclosed income from continuing operations271      
Loss from continuing operations:(10,795)(9,947)(6,920)(6,367)(112)(33)(63)
Loss from discontinued operations     (16) 
Loss before gain (loss) on sale of properties:(10,795)(9,947)(6,920)(6,367)(112)(48)(63)
Other undisclosed net loss(1)(1)(6,720)(414)   
Net loss:(10,796)(9,948)(13,640)(6,781)(112)(48)(63)
Other undisclosed net income attributable to parent     0 
Net loss available to common stockholders, diluted:(10,796)(9,948)(13,640)(6,781)(112)(48)(63)

Comprehensive Income ($ in thousands)

12/31/2021
TTM
9/30/2021
9/30/2020
9/30/2019
12/31/2017
12/31/2016
12/31/2015
Net loss:(10,796)(9,948)(13,640)(6,781)(112)(48)(63)
Comprehensive loss, net of tax, attributable to parent:(10,796)(9,948)(13,640)(6,781)(112)(48)(63)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: